Changing epidemiology of Hepatitis B and migration-a comparison of six Northern and North-Western European countries

Chu JJQ, Wörmann T, Popp J, Paetzelt G, Akmatov MK, Krämer A, Reintjes R (2013)
The European Journal Of Public Health 23(4): 642-647.

Zeitschriftenaufsatz | Veröffentlicht | Englisch
 
Download
Es wurden keine Dateien hochgeladen. Nur Publikationsnachweis!
Autor*in
Chu, Janet JunQing; Wörmann, TanjaUniBi; Popp, Johann; Paetzelt, Gunnar; Akmatov, Manas K.; Krämer, AlexanderUniBi ; Reintjes, Ralf
Abstract / Bemerkung
Background: Increased migration volume and different Hepatitis B prevalence between immigration and emigration countries have changed the Hepatitis B virus (HBV) epidemiology considerably in Northern and North-Western European migrants-receiving countries. Due to the difference in migration status monitoring, the HBV infection data on migrants are not easily comparable among those countries. The study aims were: to compare the migration status indicators used by the national surveillance system in six Northern and North-Western European countries (the Netherlands, Germany, Finland, Denmark, Sweden and the UK); to determine the impact of the migration status on HBV infection by comparing the available data on prevalence and transmission routes of Hepatitis B in the migration and the general population in the six countries; to recommend sensible indicators and pertinent measures for HBV infection surveillance and control in the region. Methods: Literature review, statistical data analysis on migration and HBV infection in the six countries; expert interviews to identify migration status indicators used in national surveillance systems. Results: Evident differences were found between the migration and the general population in Hepatitis B prevalence and transmission routes in the six countries. Migration status is monitored differently in six surveillance systems; immigrants from high/intermediate Hepatitis B endemic countries constitute a substantial proportion of HBsAg(+) and chronic cases in all six countries. Conclusions: International migration has an obvious impact on Hepatitis B prevalence in the six countries. It is important to include common migration status indicators and to collect comparable data for HBV infection surveillance in different notification systems.
Erscheinungsjahr
2013
Zeitschriftentitel
The European Journal Of Public Health
Band
23
Ausgabe
4
Seite(n)
642-647
ISSN
1101-1262
eISSN
1464-360X
Page URI
https://pub.uni-bielefeld.de/record/2622185

Zitieren

Chu JJQ, Wörmann T, Popp J, et al. Changing epidemiology of Hepatitis B and migration-a comparison of six Northern and North-Western European countries. The European Journal Of Public Health. 2013;23(4):642-647.
Chu, J. J. Q., Wörmann, T., Popp, J., Paetzelt, G., Akmatov, M. K., Krämer, A., & Reintjes, R. (2013). Changing epidemiology of Hepatitis B and migration-a comparison of six Northern and North-Western European countries. The European Journal Of Public Health, 23(4), 642-647. doi:10.1093/eurpub/cks067
Chu, Janet JunQing, Wörmann, Tanja, Popp, Johann, Paetzelt, Gunnar, Akmatov, Manas K., Krämer, Alexander, and Reintjes, Ralf. 2013. “Changing epidemiology of Hepatitis B and migration-a comparison of six Northern and North-Western European countries”. The European Journal Of Public Health 23 (4): 642-647.
Chu, J. J. Q., Wörmann, T., Popp, J., Paetzelt, G., Akmatov, M. K., Krämer, A., and Reintjes, R. (2013). Changing epidemiology of Hepatitis B and migration-a comparison of six Northern and North-Western European countries. The European Journal Of Public Health 23, 642-647.
Chu, J.J.Q., et al., 2013. Changing epidemiology of Hepatitis B and migration-a comparison of six Northern and North-Western European countries. The European Journal Of Public Health, 23(4), p 642-647.
J.J.Q. Chu, et al., “Changing epidemiology of Hepatitis B and migration-a comparison of six Northern and North-Western European countries”, The European Journal Of Public Health, vol. 23, 2013, pp. 642-647.
Chu, J.J.Q., Wörmann, T., Popp, J., Paetzelt, G., Akmatov, M.K., Krämer, A., Reintjes, R.: Changing epidemiology of Hepatitis B and migration-a comparison of six Northern and North-Western European countries. The European Journal Of Public Health. 23, 642-647 (2013).
Chu, Janet JunQing, Wörmann, Tanja, Popp, Johann, Paetzelt, Gunnar, Akmatov, Manas K., Krämer, Alexander, and Reintjes, Ralf. “Changing epidemiology of Hepatitis B and migration-a comparison of six Northern and North-Western European countries”. The European Journal Of Public Health 23.4 (2013): 642-647.

25 Zitationen in Europe PMC

Daten bereitgestellt von Europe PubMed Central.

The influence of ethnicity on disease outcome in patients with chronic hepatitis B infection.
Koc ÖM, Robaeys G, Yildirim B, Posthouwer D, Hens N, Koek GH., J Med Virol 91(4), 2019
PMID: 30381836
HIV diagnoses in migrant populations in Australia-A changing epidemiology.
Gunaratnam P, Heywood AE, McGregor S, Jamil MS, McManus H, Mao L, Lobo R, Brown G, Hellard M, Marukutira T, Bretaña NA, Lang C, Medland N, Bavinton B, Grulich A, Guy R., PLoS One 14(2), 2019
PMID: 30763366
Hepatitis B virus prevalence and risk factors in hard-to-reach Turkish population living in Belgium: A protocol for screening.
Koc ÖM, Hens N, Bielen R, Van Damme P, Robaeys G., Medicine (Baltimore) 98(18), 2019
PMID: 31045797
Assessing testing rates for viral hepatitis B and C by general practitioners in Flanders, Belgium: a registry-based study.
Bielen R, Koc ÖM, Busschots D, Robaeys G, Aertgeerts B, Vaes B, Mamouris P, Mathei C, Goderis G, Nevens F., BMJ Open 9(5), 2019
PMID: 31072855
Epidemiology of chronic hepatitis B virus in Ireland using routinely collected surveillance and administrative data, 2004-2014.
van Gemert CE, Murphy N, Mitchell TA, Hellard ME, Thornton L., Ir J Med Sci 187(3), 2018
PMID: 29224133
Time trends of chronic HBV infection over prior decades - A global analysis.
Ott JJ, Horn J, Krause G, Mikolajczyk RT., J Hepatol 66(1), 2017
PMID: 27592304
Optimizing antiviral agents for hepatitis B management in malignant lymphomas.
Ozoya OO, Chavez J, Sokol L, Dalia S., Ann Transl Med 5(3), 2017
PMID: 28251118
High rate of Hepatitis B virus infection among hairdressers in Ibadan, Nigeria.
Olusola BA, Gometi EA, Ogunsemowo O, Olaleye DO, Odaibo GN., J Immunoassay Immunochem 38(3), 2017
PMID: 28318369
Changes in the Prevalence of HBsAg and HBeAg: a Study of 8696 Parturients in a Well Vaccinated Area.
Wu CH, Hsu TY, Kung FT, ChangChien CC, Tsai CC, Lu SN., Sci Rep 7(1), 2017
PMID: 28450703
Comparison between two population-based hepatitis B serosurveys with an 8-year interval in Shandong Province, China.
Liu J, Lv J, Yan B, Feng Y, Song L, Xu A, Zhang L, Yan Y., Int J Infect Dis 61(), 2017
PMID: 28577994
Timing of chronic hepatitis B diagnosis after migration and its determinants among Sub-Saharan African migrants living in France.
Pannetier J, Gigonzac V, Lydié N, Desgrées du Loû A, Dray Spira R., PLoS One 12(12), 2017
PMID: 29283994
Epidemiological, clinical, virological features of hepatitis B newly diagnosed in 2011 in Marseille University hospitals, southeastern France.
Moussa S, Brah S, Parola P, Gerolami R, Gamerre M, Boubli L, Ruiz JM, Ravaux I, Mokhtari S, Mancini J, Romera MH, Motte A, Tamalet C, Colson P., J Med Virol 88(5), 2016
PMID: 26439319
Effectiveness and Safety of Tenofovir Disoproxil Fumarate in Chronic Hepatitis B: A 3-Year, Prospective, Real-World Study in France.
Marcellin P, Zoulim F, Hézode C, Causse X, Roche B, Truchi R, Pauwels A, Ouzan D, Dumortier J, Pageaux GP, Bourlière M, Riachi G, Zarski JP, Cadranel JF, Tilliet V, Stern C, Pétour P, Libert O, Consoli SM, Larrey D., Dig Dis Sci 61(10), 2016
PMID: 26821154
Trends in the Incidence Rates of Chronic Hepatitis B in Poland in the Years 2005 - 2013.
Stawinska-Witoszynska B, Zysnarska M, Krzywinska-Wiewiorowska M, Wojtyła-Buciorab P, Krzyzaniak A, Wieckowska B., Hepat Mon 16(8), 2016
PMID: 27799960
Enhanced surveillance of hepatitis B in the EU, 2006-2012.
Duffell EF, van de Laar MJ, Amato-Gauci AJ., J Viral Hepat 22(7), 2015
PMID: 25417854
Illness perceptions and explanatory models of viral hepatitis B & C among immigrants and refugees: a narrative systematic review.
Owiti JA, Greenhalgh T, Sweeney L, Foster GR, Bhui KS., BMC Public Health 15(), 2015
PMID: 25886390
Strategies to control hepatitis B: Public policy, epidemiology, vaccine and drugs.
Locarnini S, Hatzakis A, Chen DS, Lok A., J Hepatol 62(1 suppl), 2015
PMID: 25920093
Clinical findings in a multi-ethnic adult hepatitis B virus patient population in Denmark with emphasis on genotypic characteristics.
Brinck-Jensen NS, Erichsen P, Tarp B, Lindberg J, Kristensen LH, Erlandsen M, Petersen E, Leutscher PD, InfCare Hepatitis DK group., Scand J Gastroenterol 50(8), 2015
PMID: 25861877
Optimal management of hepatitis B virus infection - EASL Special Conference.
Lampertico P, Maini M, Papatheodoridis G., J Hepatol 63(5), 2015
PMID: 26150256
Differences in the availability of diagnostics and treatment modalities for chronic hepatitis B across Europe.
Ozaras R, Corti G, Ruta S, Lacombe K, Mondelli MU, Irwing WL, Puoti M, Khalighi A, Santos ML, Harxhi A, Lazarevic I, Soriano V, Gervain J, Leblebicioglu H, Salmon D, Arends JE, ESCMID Study Group for Viral Hepatitis., Clin Microbiol Infect 21(11), 2015
PMID: 26166544
Hepatitis B: global scientific development from a critical point of view.
Schmidt S, Bundschuh M, Scutaru C, Klingelhoefer D, Groneberg DA, Gerber A., J Viral Hepat 21(11), 2014
PMID: 24205854
Barriers to care and treatment for patients with chronic viral hepatitis in Europe: a systematic review.
Papatheodoridis GV, Tsochatzis E, Hardtke S, Wedemeyer H., Liver Int 34(10), 2014
PMID: 24750532

21 References

Daten bereitgestellt von Europe PubMed Central.

Globalization of infectious diseases: the impact of migration.
Gushulak BD, MacPherson DW., Clin. Infect. Dis. 38(12), 2004
PMID: 15227621
The basic principles of migration health: population mobility and gaps in disease prevalence.
Gushulak BD, MacPherson DW., Emerg Themes Epidemiol 3(), 2006
PMID: 16674820

AUTHOR UNKNOWN, VIRAL HEPATITIS 12(), 2004

AUTHOR UNKNOWN, VIRAL HEPATITIS 17(), 2009
The importance of imported infections in maintaining hepatitis B in The Netherlands.
Veldhuijzen IK, Smits LJ, van de Laar MJ., Epidemiol. Infect. 133(1), 2005
PMID: 15724718
[Does migration from high and intermediate endemic regions increase the prevalence of hepatitis B infection in Germany?]
Marschall T, Kramer A, Prufer-Kramer L, Mikolajczyk R, Kretzschmar M., Dtsch. Med. Wochenschr. 130(48), 2005
PMID: 16307403
[Epidemiology of hepatitis B in Germany].
Niederau C., Med. Klin. (Munich) 102(5), 2007
PMID: 17497085

AUTHOR UNKNOWN, Pediatr. Infect. Dis. J. 30(), 2010

AUTHOR UNKNOWN, VIRAL HEPATITIS 12(), 2004
Twenty-year survey of the epidemiology of hepatitis B in Denmark: effect of immigration.
Gjorup IE, Smith E, Borgwardt L, Skinhoj P., Scand. J. Infect. Dis. 35(4), 2003
PMID: 12839156

AUTHOR UNKNOWN, Euro Surveill. 10(), 2005
Acute hepatitis B in Western Sweden--genotypes and transmission routes.
Lindh M, Horal P, Norkrans G., Infection 28(3), 2000
PMID: 10879641
Incidence and routes of transmission of hepatitis B virus in England and Wales, 1995-2000: implications for immunisation policy.
Hahne S, Ramsay M, Balogun K, Edmunds WJ, Mortimer P., J. Clin. Virol. 29(4), 2004
PMID: 15018847

AUTHOR UNKNOWN, VIRAL HEPATITIS 14(), 2006
Hepatitis B virus infection in a group of heterosexuals with multiple partners in Amsterdam, The Netherlands: implications for vaccination?
Van Doornum GJ, Van Haastrecht HJ, Hooykaas C, Van den Hoek JA, Van der Linden MM, Coutinho RA., J. Med. Virol. 43(1), 1994
PMID: 8083646
The economic burden of hepatitis B in Germany.
Harbarth S, Szucs T, Berger K, Jilg W., Eur. J. Epidemiol. 16(2), 2000
PMID: 10845268

AUTHOR UNKNOWN, Euro Surveill. 10(), 2005
The reach of a free hepatitis B vaccination programme: results of a Dutch study among drug users.
Baars JE, Boon BJ, Garretsen HF, van de Mheen D., Int. J. Drug Policy 21(3), 2009
PMID: 19700297
Hepatitis B vaccination targeted at behavioural risk groups in the Netherlands: does it work?
van Houdt R, Koedijk FD, Bruisten SM, Coul EL, Heijnen ML, Waldhober Q, Veldhuijzen IK, Richardus JH, Schutten M, van Doornum GJ, de Man RA, Hahne SJ, Coutinho RA, Boot HJ., Vaccine 27(27), 2009
PMID: 19464531
Benefits of early hepatitis B immunization programs for newborns and infants.
Van Herck K, Van Damme P., Pediatr. Infect. Dis. J. 27(10), 2008
PMID: 18776823
Export

Markieren/ Markierung löschen
Markierte Publikationen

Open Data PUB

Web of Science

Dieser Datensatz im Web of Science®
Quellen

PMID: 23132874
PubMed | Europe PMC

Suchen in

Google Scholar